Otomagnetics Joins Those Who Observe Better Hearing and Speech Month
Each year in May, concerned organizations join together in observance of Better Hearing and Speech Month. This time provides an opportunity to raise awareness and to educate others about communication disorders, the treatments that are available, and to explore new research that could improve the lives of those with an impairment.
Around 46 million people in the U.S. experience some form of communication disorder and according to the National Institute on Deafness and Other Communication Disorders (NIDCD), approximately 28 million people suffer from a hearing loss. Currently, the World Health Organization (WHO) reports that worldwide roughly 466 million people have disabling hearing loss, and 34 million of these are children. These disorders can impact many areas in quality of life including not only physical and emotional health, but also social, educational, career or occupation, and recreational aspects.
The Center for Disease Control (CDC) reports that a child's ability to develop communication, language, and social skills can be affected by hearing loss. In fact, children who experience hearing disorders often find it much more difficult to learn the characteristics of verbal communication including vocabulary and grammar, than children who have normal hearing. However, the World Health Organization (WHO) reports that 60% of childhood hearing loss is due to preventable causes.
Yet, new research may soon help to prevent some causes of hearing loss and may improve the lives of many others. Otomagnetics is developing a magnetic injection delivery system that may be able to deliver therapy to areas of the body that are not effectively reached by the current standards-of-care, or that would otherwise require surgery to reach. If you would like to find out more information about Otomagnetics' research, please visit www.otomagnetics.com.
Otomagnetics welcomes advocacy organizations, private industry, foundations, or individuals who have a shared interest and wish to partner with them in advancing their goals.
Otomagnetics technology has not been approved for any use by the United States Food and Drug Administration. The technology is in early stage development and is not available for sale, clinical use, or otherwise.
